
ImmuBYTES Session 3 Video Recording
Early detection of pulmonary ADC toxicity using ImmuONE’s morph_ONE™ high-content imaging assay of alveolar macrophages to improve safety and efficacy in ADC drug development.
ImmuONE entered the Santander Universities Entrepreneurship Awards representing the University of Hertfordshire. After successfully completing the first two rounds they are through to the semi-finals on the 27th of June.
Early detection of pulmonary ADC toxicity using ImmuONE’s morph_ONE™ high-content imaging assay of alveolar macrophages to improve safety and efficacy in ADC drug development.
In ImmuBYTES Session 3, “Looking Beyond Baseline Deviations for Lung and Immune Safety,” Prof. Victoria Hutter (CSO & Co-founder) highlighted how subtle changes in macrophage morphology can uncover early immune and lung effects.
Early detection of pulmonary ADC toxicity using ImmuONE’s morph_ONE™ high-content imaging assay of alveolar macrophages to improve safety and efficacy in ADC drug development.
Make Every Breath Safe
Sycamore House
16 Leyden Road
Stevenage, Hertfordshire, UK
SG1 2BP
Copyright 2025 ImmuONE.
All rights reserved.